Drug Shortage Report for SUPREFACT
Report ID | 169133 |
Drug Identification Number | 02225166 |
Brand name | SUPREFACT |
Common or Proper name | Buserelin |
Company Name | CHEPLAPHARM ARZNEIMITTEL GMBH |
Market Status | MARKETED |
Active Ingredient(s) | BUSERELIN |
Strength(s) | 1MG |
Dosage form(s) | SOLUTION |
Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
Packaging size | 5.5 mL / vial |
ATC code | L02AE |
ATC description | HORMONES AND RELATED AGENTS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2022-09-08 |
Estimated end date | 2022-12-31 |
Actual end date | 2022-12-07 |
Shortage status | Resolved |
Updated date | 2022-12-08 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | ZIEGELHOF 24 GREIFSWALD, MECKLENBURG - WEST POMERANIA GERMANY 17489 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2022-12-08 | English | Compare |
v8 | 2022-12-07 | French | Compare |
v7 | 2022-12-07 | English | Compare |
v6 | 2022-11-30 | French | Compare |
v5 | 2022-11-30 | English | Compare |
v4 | 2022-10-27 | French | Compare |
v3 | 2022-10-27 | English | Compare |
v2 | 2022-09-12 | French | Compare |
v1 | 2022-09-12 | English | Compare |
Showing 1 to 9 of 9